Table 1 Demographic characterization of the MESA participants across race/ethnic groups.
Participant characteristics | Pooled | White | Chinese | African-American | Hispanic |
|---|---|---|---|---|---|
No. subjects | 3867 | 1573 | 467 | 876 | 887 |
Women | 1960 (50.7) | 782 (49.7) | 231 (49.5) | 456 (52.1) | 447 (50.4) |
Age, years | 61 (53,69) | 61 (53,69) | 61 (52,69) | 61 (53,68) | 60 (52,68) |
Current smoke (yes/no) | 462 (12.0) | 172 (10.9) | 28 (6.0) | 151 (17.2) | 106 (12.0) |
Lipid medication (yes/no) | 620 (16.0) | 274 (17.4) | 73 (15.6) | 129 (14.7) | 126 (14.2) |
BMI, kg/m2 | 27.5 [24.5, 30.9] | 27.2 [24.3, 30.3] | 23.9 [22.0, 26.1] | 29.2 [26.3, 33.2] | 28.6 [26.0, 31.7] |
fasting glucose (mg/dl) | 89 [82,98] | 87 [81,94] | 91 [85, 101] | 91 [83, 101] | 92 [84, 103] |
Systolic blood pressure (SBP) (mmHg) | 122 [111, 138] | 120 [110, 135] | 120 [108, 137] | 129 [116, 142] | 122 [111, 139] |
Diastolic blood pressure (DBP) (mmHg) | 72 [65,79] | 71 [64,78] | 72 [66,78] | 74 [68,81] | 72 [65,79] |
HDL-C, mg/dl | 48 (40,59) (n = 3865) | 50 (41,61) (n = 1572) | 48 (40,55) (n = 467) | 50 (41,60) (n = 875) | 45 (39,54) (n = 887) |
LDL-C, mg/dl | 116 [96, 136] (n = 3819) | 115 [96, 136] (n = 1555) | 113 [96, 131] (n = 467) | 117 [96, 136] (n = 872) | 119 [99, 138] (n = 869) |
Triglycerides, mg/dl | 113 [78, 163] (n = 3867) | 113 [77, 165] (n = 1573) | 128 [87, 170] (n = 467) | 90 [66, 121] (n = 876) | 135 [97, 191] (n = 887) |
LAG3 protein levels (Ex 1), RFU | 6420.8 [5422.5, 7773.1] (n = 833) | 6401.1 [5360.9, 7802.6] (n = 352) | 7709.4 [6432.2, 9100.4] (n = 62) | 6203.7 [5194.9, 7106.0] (n = 154) | 6388.1 [5512.6, 7533.3] (n = 248) |
LAG3 protein levels (pg/ml) (Ex 2) | 496 [231, 1340] (n = 3612) | 447 [206, 1144] (n = 1526) | 674 [322, 1603] (n = 462) | 536 [202, 2461] (n = 881) | 505 [261, 1168] (n = 847) |
Presence of calcium indicator (yes/no) | 1806 (47.3) (n = 3819) | 819 (52.7) (n = 1555) | 221 (47.3) (n = 467) | 358 (41.1) (n = 872) | 375 (43.2) (n = 869) |
Agatston calcium score (among those with CAC > 0) | 77.9 [18.9, 274.2] (n = 1806) | 99.7 [20.2, 328.8] (n = 819) | 67.1 [25.5, 221.5] (n = 221) | 53.1 [17.2, 232.5] (n = 358) | 73.8 [18.9, 248.0] (n = 375) |
Common carotid intimal-medical thickness (mm) | 0.84 [0.73, 0.96] (n = 3804) | 0.83 [0.72, 0.96] (n = 1549) | 0.80 [0.70, 0.91] (n = 467) | 0.88 [0.76, 1.00] (n = 866) | 0.82 [0.73, 0.93] (n = 866) |
Internal carotid intimal-medical thickness (mm) | 0.84 [0.68, 1.20] (n = 3746) | 0.87 [0.71, 1.31] (n = 1532) | 0.73 [0.60, 0.88] (n = 462) | 0.85 [0.67, 1.28] (n = 850) | 0.82 [0.66, 1.15] (n = 847) |
Ankle-brachial index (ABI) | 1.13 [1.06, 1.19] (n = 3788) | 1.14 [1.07, 1.20] (n = 1540) | 1.12 [1.07, 1.18] (n = 466) | 1.10 [1.03, 1.16] (n = 863) | 1.14 [1.08, 1.20] (n = 865) |
Stroke (yes/no) | 179 (0.047) (n = 3816) | 72 (0.046) (n = 1553) | 17 (0.036) (n = 467) | 35 (0.040) (n = 872) | 54 (0.062) (n = 868) |
Myocardial infarction (MI) (yes/no) | 188 (0.049) (n = 3816) | 84 (0.054) (n = 1553) | 17 (0.036) (n = 467) | 34 (0.039) (n = 872) | 51 (0.059) (n = 868) |
Follow-up time (days) | 5539 [5317, 5745] | 5610 [5357, 5791] | 5538 [5311, 5745] | 5456 [5280, 5658] | 5509 [5289, 5738] |